Anchor Therapeutics, Inc.

In late 2012, a scientific paper questioned the ability of stapled peptides, one of the most highly touted and advanced of the new generation of constrained peptide therapeutics, to penetrate cells an

In late 2012, a scientific paper questioned the ability of stapled peptides, one of the most highly touted and advanced of the new generation of constrained peptide therapeutics, to penetrate cells an

IN VITRO DIAGNOSTICS Mergers & Acquisitions Life Technologies Corp. Navigenics Inc. In an initial move to build up its molecular diagnostics business, Life Technologies Corp. is buying privately h

An agile and energetic cohort of biotech platform companies plans to capture Big Pharma's imagination – and its pocketbook – by going after intractable drug targets that have long eluded the industry,